Skip to content

Bipolar Disorder in Pregnancy and the Postpartum Period: Predictors of Morbidity

Bipolar Disorder in Pregnancy and the Postpartum Period: Predictors of Morbidity

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00580268
Enrollment
118
Registered
2007-12-24
Start date
2005-08-31
Completion date
2013-07-31
Last updated
2014-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, Neonatal Outcome, Psychiatric Morbidity

Brief summary

The purpose of this study is to examine risk factors for relapse of bipolar disorder during pregnancy and the postpartum period. The main goal of this study is to find the risks that may make it more likely for a woman with bipolar disorder to experience a depressive, manic, or hypomanic episode during her pregnancy and the postpartum period.

Interventions

None listed

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. medically healthy adult women (ages 18-45) fulfilling DSM-IV criteria for bipolar disorder of any type (1 or 2) who are currently pregnant within 14 weeks gestation dated by last menstrual period; 2. euthymic at the time of conception; 3. able to give informed consent and comply with study procedures; 4. have a treating psychiatrist, physician or mental health clinician. Gravid women between the ages of 18 and 45

Exclusion criteria

1. active suicidality or homicidality; 2. active substance use disorder with 6 months prior to enrollment, or 3. positive urine drug screen at enrollment.

Design outcomes

Primary

MeasureTime frame
psychiatric morbidity15 months

Secondary

MeasureTime frame
obstetrical outcomes6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026